Phase 2 High-Risk Acute Myeloid Leukemia Clinical Trials

2 recruitingPhase 2

What is a Phase 2 trial?

Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.

Showing 1–2 of 2 trials

Recruiting

Phase 1Phase 2

Phase 1/2: CD45RA Depleted Stem Cell Addback to Prevent Viral or Fungal Infections Post TCRab/CD19 Depleted HSCT

LeukemiaInborn Errors of MetabolismHLH+11 more

Children's Hospital of Philadelphia100 enrolled1 locationNCT06839456

Recruiting

Phase 2

Study of VA Combined With HAAG Regimen in Newly Diagnosed Intermediate and High-risk AML Patients

High-Risk Acute Myeloid LeukemiaIntermediate Risk Acute Myeloid Leukemia

The First Affiliated Hospital of Soochow University60 enrolled1 locationNCT06394011